Clopamide is an oral diuretic agent with antihypertensive activity. Like thiazide diuretics, it has an aromatic sulfonamide base but with no double-ring structure.
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Nicotine | The risk or severity of adverse effects can be increased when Clopamide is combined with Nicotine. |
| Mecamylamine | The risk or severity of adverse effects can be increased when Clopamide is combined with Mecamylamine. |
| Pentolinium | The risk or severity of adverse effects can be increased when Clopamide is combined with Pentolinium. |
| Trimethaphan | The risk or severity of adverse effects can be increased when Clopamide is combined with Trimethaphan. |
| Hexamethonium | The risk or severity of adverse effects can be increased when Clopamide is combined with Hexamethonium. |
| Cyclopentamine | The risk or severity of adverse effects can be increased when Clopamide is combined with Cyclopentamine. |
| Methotrexate | The protein binding of Methotrexate can be increased when combined with Clopamide. |
| Dexketoprofen | The risk or severity of adverse effects can be increased when Dexketoprofen is combined with Clopamide. |
| Ketoprofen | The risk or severity of adverse effects can be increased when Ketoprofen is combined with Clopamide. |
| Cyclosporine | The risk or severity of renal failure can be increased when Clopamide is combined with Cyclosporine. |
| Sodium phosphate, monobasic | Clopamide may increase the nephrotoxic activities of Sodium phosphate, monobasic. |
| Acemetacin | The therapeutic efficacy of Clopamide can be decreased when used in combination with Acemetacin. |
| Lactulose | The risk or severity of dehydration can be increased when Clopamide is combined with Lactulose. |
| Magnesium sulfate | The risk or severity of dehydration can be increased when Clopamide is combined with Magnesium sulfate. |
| Mannitol | The risk or severity of dehydration can be increased when Clopamide is combined with Mannitol. |
| Lubiprostone | The risk or severity of dehydration can be increased when Clopamide is combined with Lubiprostone. |
| Tegaserod | The risk or severity of dehydration can be increased when Clopamide is combined with Tegaserod. |
| Magnesium oxide | The risk or severity of dehydration can be increased when Clopamide is combined with Magnesium oxide. |
| Magnesium cation | The risk or severity of dehydration can be increased when Clopamide is combined with Magnesium cation. |
| Sorbitol | The risk or severity of dehydration can be increased when Clopamide is combined with Sorbitol. |
| Dantron | The risk or severity of dehydration can be increased when Clopamide is combined with Dantron. |
| Oxyphenisatin | The risk or severity of dehydration can be increased when Clopamide is combined with Oxyphenisatin. |
| Phenolphthalein | The risk or severity of dehydration can be increased when Clopamide is combined with Phenolphthalein. |
| Prucalopride | The risk or severity of dehydration can be increased when Clopamide is combined with Prucalopride. |
| Emodin | The risk or severity of dehydration can be increased when Clopamide is combined with Emodin. |
| Linaclotide | The risk or severity of dehydration can be increased when Clopamide is combined with Linaclotide. |
| Bisacodyl | The risk or severity of dehydration can be increased when Clopamide is combined with Bisacodyl. |
| Magnesium hydroxide | The risk or severity of dehydration can be increased when Clopamide is combined with Magnesium hydroxide. |
| Bisoxatin | The risk or severity of dehydration can be increased when Clopamide is combined with Bisoxatin. |
| Picosulfuric acid | The risk or severity of dehydration can be increased when Clopamide is combined with Picosulfuric acid. |
| Magnesium trisilicate | The risk or severity of dehydration can be increased when Clopamide is combined with Magnesium trisilicate. |
| Polyethylene glycol | The risk or severity of dehydration can be increased when Clopamide is combined with Polyethylene glycol. |
| Polycarbophil | The risk or severity of dehydration can be increased when Clopamide is combined with Polycarbophil. |
| Magnesium acetate tetrahydrate | The risk or severity of dehydration can be increased when Clopamide is combined with Magnesium acetate tetrahydrate. |
| Monopotassium phosphate | The risk or severity of dehydration can be increased when Clopamide is combined with Monopotassium phosphate. |
| Dipotassium phosphate | The risk or severity of dehydration can be increased when Clopamide is combined with Dipotassium phosphate. |
| Glycerin | The risk or severity of dehydration can be increased when Clopamide is combined with Glycerin. |
| Sodium sulfate | The risk or severity of dehydration can be increased when Clopamide is combined with Sodium sulfate. |
| Magnesium carbonate | The risk or severity of dehydration can be increased when Clopamide is combined with Magnesium carbonate. |
| Potassium lactate | The risk or severity of dehydration can be increased when Clopamide is combined with Potassium lactate. |
| Sodium fluorophosphate | The risk or severity of dehydration can be increased when Clopamide is combined with Sodium fluorophosphate. |
| Mineral oil | The risk or severity of dehydration can be increased when Clopamide is combined with Mineral oil. |
| Carboxymethylcellulose | The risk or severity of dehydration can be increased when Clopamide is combined with Carboxymethylcellulose. |
| Docusate | The risk or severity of dehydration can be increased when Clopamide is combined with Docusate. |
| Plantago seed | The risk or severity of dehydration can be increased when Clopamide is combined with Plantago seed. |
| Magnesium citrate | The risk or severity of dehydration can be increased when Clopamide is combined with Magnesium citrate. |
| Castor oil | The risk or severity of dehydration can be increased when Clopamide is combined with Castor oil. |
| Magnesium glycinate | The risk or severity of dehydration can be increased when Clopamide is combined with Magnesium glycinate. |
| Methylcellulose | The risk or severity of dehydration can be increased when Clopamide is combined with Methylcellulose. |
| Sennosides | The risk or severity of dehydration can be increased when Clopamide is combined with Sennosides. |
| Lactitol | The risk or severity of dehydration can be increased when Clopamide is combined with Lactitol. |
| Plecanatide | The risk or severity of dehydration can be increased when Clopamide is combined with Plecanatide. |
| Gluconic Acid | The risk or severity of dehydration can be increased when Clopamide is combined with Gluconic Acid. |
| Magnesium peroxide | The risk or severity of dehydration can be increased when Clopamide is combined with Magnesium peroxide. |
| Pentaerithrityl | The risk or severity of dehydration can be increased when Clopamide is combined with Pentaerithrityl. |
| Sodium tartrate | The risk or severity of dehydration can be increased when Clopamide is combined with Sodium tartrate. |
| Magnesium acetate | The risk or severity of dehydration can be increased when Clopamide is combined with Magnesium acetate. |
| Deacetylbisacodyl | The risk or severity of dehydration can be increased when Clopamide is combined with Deacetylbisacodyl. |
| Sodium ascorbate | The risk or severity of dehydration can be increased when Clopamide is combined with Sodium ascorbate. |
| Potassium sulfate | The risk or severity of dehydration can be increased when Clopamide is combined with Potassium sulfate. |
| Sodium phosphate, dibasic | The risk or severity of dehydration can be increased when Clopamide is combined with Sodium phosphate, dibasic. |
| Sodium phosphate, monobasic, unspecified form | The risk or severity of dehydration can be increased when Clopamide is combined with Sodium phosphate, monobasic, unspecified form. |
| Sodium phosphate, dibasic, unspecified form | The risk or severity of dehydration can be increased when Clopamide is combined with Sodium phosphate, dibasic, unspecified form. |
| Sodium cation | The risk or severity of dehydration can be increased when Clopamide is combined with Sodium cation. |
| Plantago ovata seed | The risk or severity of dehydration can be increased when Clopamide is combined with Plantago ovata seed. |
| Oxyphenisatin acetate | The risk or severity of dehydration can be increased when Clopamide is combined with Oxyphenisatin acetate. |
| Calcium polycarbophil | The risk or severity of dehydration can be increased when Clopamide is combined with Calcium polycarbophil. |
| Konjac mannan | The risk or severity of dehydration can be increased when Clopamide is combined with Konjac mannan. |
| Alloin | The risk or severity of dehydration can be increased when Clopamide is combined with Alloin. |
| Frangula purshiana bark | The risk or severity of dehydration can be increased when Clopamide is combined with Frangula purshiana bark. |
| Dehydrocholic acid | The risk or severity of dehydration can be increased when Clopamide is combined with Dehydrocholic acid. |
| Sulfate ion | The risk or severity of dehydration can be increased when Clopamide is combined with Sulfate ion. |
| Insulin human | The risk or severity of hypoglycemia can be increased when Clopamide is combined with Insulin human. |
| Insulin lispro | The risk or severity of hypoglycemia can be increased when Clopamide is combined with Insulin lispro. |
| Insulin glargine | The risk or severity of hypoglycemia can be increased when Clopamide is combined with Insulin glargine. |
| Insulin pork | The risk or severity of hypoglycemia can be increased when Clopamide is combined with Insulin pork. |
| Troglitazone | The therapeutic efficacy of Troglitazone can be increased when used in combination with Clopamide. |
| Glimepiride | The therapeutic efficacy of Glimepiride can be increased when used in combination with Clopamide. |
| Sulfisoxazole | The therapeutic efficacy of Sulfisoxazole can be increased when used in combination with Clopamide. |
| Disopyramide | The therapeutic efficacy of Disopyramide can be increased when used in combination with Clopamide. |
| Acarbose | The therapeutic efficacy of Acarbose can be increased when used in combination with Clopamide. |
| Metformin | The therapeutic efficacy of Metformin can be increased when used in combination with Clopamide. |
| Sulfadiazine | The therapeutic efficacy of Sulfadiazine can be increased when used in combination with Clopamide. |
| Rosiglitazone | The therapeutic efficacy of Rosiglitazone can be increased when used in combination with Clopamide. |
| Acetohexamide | The therapeutic efficacy of Acetohexamide can be increased when used in combination with Clopamide. |
| Quinine | The therapeutic efficacy of Quinine can be increased when used in combination with Clopamide. |
| Miglitol | The therapeutic efficacy of Miglitol can be increased when used in combination with Clopamide. |
| Chlorpropamide | The therapeutic efficacy of Chlorpropamide can be increased when used in combination with Clopamide. |
| Nateglinide | The therapeutic efficacy of Nateglinide can be increased when used in combination with Clopamide. |
| Pentamidine | The therapeutic efficacy of Pentamidine can be increased when used in combination with Clopamide. |
| Mifepristone | The therapeutic efficacy of Mifepristone can be increased when used in combination with Clopamide. |
| Tolazamide | The therapeutic efficacy of Tolazamide can be increased when used in combination with Clopamide. |
| Repaglinide | The therapeutic efficacy of Repaglinide can be increased when used in combination with Clopamide. |
| Phenformin | The therapeutic efficacy of Phenformin can be increased when used in combination with Clopamide. |
| Sulfamethoxazole | The therapeutic efficacy of Sulfamethoxazole can be increased when used in combination with Clopamide. |
| Glyburide | The therapeutic efficacy of Glyburide can be increased when used in combination with Clopamide. |
| Glipizide | The therapeutic efficacy of Glipizide can be increased when used in combination with Clopamide. |
| Gliclazide | The therapeutic efficacy of Gliclazide can be increased when used in combination with Clopamide. |
| Tolbutamide | The therapeutic efficacy of Tolbutamide can be increased when used in combination with Clopamide. |
| Pioglitazone | The therapeutic efficacy of Pioglitazone can be increased when used in combination with Clopamide. |